Thank you for an excellent and accurate response. The only time a placebo or no treatment is allowed in an oncology trial is when no standard treatment exists. Even in these studies, the patient receives what is called "best supportive care," drugs for comfort and to control disease symptoms. The National Cancer Institute website has a great website that discusses this and other issues that patients considering a clinical trial should consider. http://www.cancer.gov/clinicaltrials/learning/should-I-take-part
In the PRECEDENT Study, participants are treated either with Doxil, an FDA approved drug used to treat ovarian cancer, or with a combination of Doxil and EC145, the investigational drug.
Dave Morgenstern
Director, Clinical Affairs
Endocyte, Inc.
Comment Reply
Annette,
Thank you for an excellent and accurate response. The only time a placebo or no treatment is allowed in an oncology trial is when no standard treatment exists. Even in these studies, the patient receives what is called "best supportive care," drugs for comfort and to control disease symptoms. The National Cancer Institute website has a great website that discusses this and other issues that patients considering a clinical trial should consider. http://www.cancer.gov/clinicaltrials/learning/should-I-take-part
In the PRECEDENT Study, participants are treated either with Doxil, an FDA approved drug used to treat ovarian cancer, or with a combination of Doxil and EC145, the investigational drug.
Dave Morgenstern
July 16, 2009 - 8:41amDirector, Clinical Affairs
Endocyte, Inc.
This Comment
Reply